BACKGROUND/OBJECTIVES: Fatty-acid status during in-utero development might influence the risk of atopic diseases in early childhood. The aim of this work was to identify the relationship between maternal plasma and cord blood fatty acid (FA) composition and the risk of atopic eczema in the offspring at 14 months of age. SUBJECTS/METHODS: Two hundred and eleven non-atopic mothers and their children were studied. Mothers were recruited in their first trimester of gestation and children were monitored until 14 months of age. Samples of maternal plasma and cord blood plasma were analyzed to determine the FA profile of total lipids. Presence of atopic eczema in the infants was documented through questionnaires at 6 and 14 months of age. RESULTS: Higher concentrations of total long-chain polyunsaturated FA (LC-PUFA) were found in maternal plasma of non-atopic children in relation to atopic group. Moreover, this maternal plasma LC-PUFA content was negatively correlated with the atopic eczema (odds ratios (OR) ¼ 0.83, P ¼ 0.04) in infants. Regarding cord blood samples, docosahexaenoic acid (DHA C22:6n3) and the sum of total n-3 and of LC-PUFA n-3 showed a negative correlation with the prevalence of the disease (OR ¼ 0.50, 0.49 and 0.49, respectively). CONCLUSIONS: Our results show that the fatty-acid status of the fetus during pregnancy has an important role in the development of atopic eczema in early childhood. The prevalence of this atopic disorder is related to lower cord blood plasma levels of FA belonging to n-3 series, especially DHA.
INTRODUCTION
Several studies show that maternal intake of fatty acids (FA) during pregnancy is a major determinant of the FA status of infants at birth. Within FA, long-chain polyunsaturated FA (LC-PUFA) have an important role in infant growth and development through their functions in membrane lipids, as ligands for receptors and transcription factors that regulate gene expression, as eicosanoid precursors, and through direct interactions with proteins. 1 The synthesis of LC-PUFA by the human placenta and fetus is limited, and therefore the main source of fetus LC-PUFA must be maternal plasma via the umbilical cord. 2 The prevalence of atopic diseases in children is a matter of worldwide concern, as it has increased over the last few decades and affects infants at an early age. One of the main atopic manifestations in children under 2 years of age is eczema, a pruritic inflammatory skin disease. 3 Genetic factors have been proposed as important risk factors for atopy. 4 It was therefore important to select a study group of mothers without a clinical history of atopy who presented a negligible contribution to their children's diseases.
The relationship between LC-PUFA and atopy has been widely investigated. Initial studies revealed increased levels of linoleic acid (LA C18:2n6) and lower levels of its long-chain derivatives in the plasma of patients with diagnosed atopic eczema. 5 Several subsequent studies have reported that a decrease in the intake of n-3 PUFA and an increase in the intake of n-6 PUFA, particularly LA may lead to an increase in atopic diseases. 6, 7 These findings may be attributed to the fact that the PUFA from different families are precursors for the production of eicosanoid mediators, such as prostaglandins and leukotrienes, which are involved in immunoregulation and inflammatory processes. 8, 9 On one hand, higher concentrations of n-6 PUFA enhance the synthesis of proinflammatory eicosanoids, prostaglandins of 2-series (such as PGE2) and leukotrienes of 4-series (such as LTB4). These mediators favor allergic inflammation and IgE response. 10 On the other hand, n-3 PUFA gives rise to alternative mediators that are significantly less inflammatory and, moreover, favor the production of resolvins, which act by decreasing inflammation. 11, 12 The differences in lipid-mediator activity could lead to the conclusion that n-3 PUFA, conversely to n-6 PUFA, might reduce the risk of developing atopic diseases, although more comprehensive studies are needed. 10, 13 Several studies have been performed to establish associations between maternal diet and the FA status of infants. 14, 15 Authors have attempted to find a relationship between the occurrence of certain series of FA (specially n-3 and n-6) in different biological matrices involved in the child FA supply, such as breast milk, [16] [17] [18] [19] [20] maternal plasma 6, 17 and the umbilical cord, 21, 22 with the subsequent development of atopic diseases. The results obtained have been inconsistent. Whereas some works show an important relationship between atopic manifestations and a lower presence of n-3 FA in breast milk or cord blood, 16, 19, 22, 23 other authors have found the opposite trend. 18 In some cases the populations under study were too small or did not take into account other factors, such as parental atopy, which affect the occurrence of atopy in children.
In this study, the maternal plasma and cord blood fatty-acid profiles for atopic and non-atopic children from healthy mothers were compared. Moreover, correlations between FA from samples of cord blood and maternal plasma were evaluated.
SUBJECTS AND METHODS

Study design and participants
Data for this study were obtained from a population-based birth cohort established in the city of Sabadell (Catalonia, Spain) as part of the project Infancia y Medio Ambiente (INMA). INMA is a network of birth cohorts in Spain that aim to study the role of environmental pollutants in air, water and diet during pregnancy and early childhood in relation to child growth and development. 24 Between July 2004 and July 2006, pregnant women who visited Sabadell public health center for an ultrasound in the first trimester were recruited, based on certain criteria (over 16 years of age, intention to deliver in the reference hospital, no communication problems, singleton pregnancy and no assisted conception). Maternal blood samples were extracted during the 12th week of gestation. Venous cord blood samples were obtained from the umbilical cord during delivery. Although 363 pairs of samples' maternal and cord blood plasma were collected, only mothers who presented values of specific IgE antibodies o0.35 kU/l were included in the study. Thus, the final population consisted of 211 mother-child pairs. The FA composition of cord blood and maternal plasma was analyzed.
Information on parental characteristics, including education, socioeconomic background (using the International Standard Classification of Occupations codes), siblings at birth, smoking habits and other variables, was obtained by interviewer-administered questionnaires with mothers when the child was 6-and 14-month-old.
Informed consent was obtained from all participants and the study was approved by the Clinical Research Ethical Committee of the Municipal Institute of Health Care (CEIC-IMAS), Barcelona, Spain.
Definition of atopy
Maternal atopy was defined according to specific IgE antibodies against cat dander, mite and Poaceae plants, which represent the most common allergens in Spain. A woman was considered to be atopic if at least one of the measured specific IgE antibodies had values X0.35 kU/l, as serumspecific IgE may be considered biomarkers for identifying the allergic phenotype. 25 Previous studies have revealed that maternal atopy, to a much higher degree than paternal atopy, is a key factor that influences the further development of infant atopy. 23 In this study, only non-atopic mothers (IgEo0.35) were considered, thus minimizing hereditary factors. Information about atopic eczema was obtained from parents through two questionnaires completed when the child was 6-and 14-month-old. Atopic eczema was defined as a positive response to the question, ''Has your child ever experienced atopic eczema since birth to 6 months, and from 7 to 14 months?''. Thus, children whose parents reported that they had been diagnosed with eczema during both periods (recurrent eczema) were classified as atopics.
Plasma fatty-acid analysis
Blood samples were collected from mothers and babies in the aforementioned periods. The plasma samples were stored at À 80 1C until the assays were conducted.
Total FA were analyzed by fast-gas chromatography in accordance with a slightly modified version of Bondia-Pons et al. 26 Hundred microlitres of sample were saponified by adding 1 ml of sodium methylate (0.5% w/v) and heating to 100 1C for 15 min. After cooling to 25 1C, samples were esterified at 100 1C for 15 min using 1 ml of boron trifluoride-methanol reagent. Subsequently, fatty-acid methyl esters were isolated by adding 500 ml of n-hexane. After shaking for 1 min, 1 ml of a saturated sodium chloride solution was added. Finally, the tubes were centrifuged for 8 min at 2200 g. Anhydrous sodium sulphate was added to eliminate aqueous residues. The n-hexane top layer was transferred into an automatic injector vial equipped with a volume adapter of 300 ml.
Fast-gas chromatography analyses were performed on a Shimadzu GC-2010 gas chromatograph equipped with a flame ionization detector (Shimadzu, Kyoto, Japan). Separation of fatty-acid methyl esters was carried out on a capillary column (10 m Â 0.10 mm i.d. Â 0.10 mm film thickness) coated with a Varian VF-23 ms high cyanopropyl stationary phase (Varian, Palo Alto, CA, USA). Helium was used as the carrier gas and the injector was used in split mode (1:30) . The temperature program was as follows: initial temperature 120 1C, a first ramp at 35 1C/min to 175 1C (hold for 1.5 min) and a second ramp at 20 1C/min to 250 1C. Injector and detector were maintained at 250 1C and 300 1C, respectively. Data acquisition and processing were performed with Shimadzu-ChemStation software (Shimadzu) for gas chromatography systems.
Statistics
Means and s.d. were used to describe continuous variables. The Kolmogorov-Smirnov test was used to study the normal distribution of fatty-acid percentages. Those FA that did not present a normal distribution were naturally log-transformed.
Logistic regression was applied to estimate the effect of each FA separately on the dichotomous outcome (atopic eczema). The logistic models obtained were adjusted by six potential confounders: the sex of the child, maternal social class, maternal education, breastfeeding, maternal smoking during pregnancy and parity.
Correlations between plasma and cord blood FA were analyzed by Spearman's rank correlation coefficient (r). All statistical analyses were performed on SPSS 18.0 for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
The baseline characteristics of the participants according to the child's atopic eczema status are shown in Table 1 . A statistical analysis showed no significant differences in these baseline characteristics between the two groups of children studied. Thus, it was expected that these variables presented a negligible influence on the development of disease.
The levels of FA measured in the maternal plasma and cord blood for both groups, atopic and non-atopic infants, are shown in Table 2 . The most abundant FA in maternal plasma was C18:2n6 (LA), which represented 32.8% of the total FA. Arachidonic acid was the main LC-PUFA, with a concentration of over 7% of the total. Nevertheless, arachidonic acid was found in much higher levels in the cord blood samples (around 13%), whereas LA only represented 12.4% of the total. It should be noted that the total n-3 fatty-acid content was higher in the cord blood samples and, conversely, n-6 FA appeared in higher proportion in the maternal plasma samples. With regard to monounsaturated FA, the levels were similar in both matrices.
Spearman correlations between the FA determined in cord blood and maternal plasma were analyzed. As expected, each FA in maternal plasma was strongly correlated with its analogous FA in the cord blood (data not shown).
No single FA in maternal plasma was significantly associated with eczema at 14 months, even after adjustment for confounders (see Table 3 ). However, when FA were analyzed by group, LC-PUFA showed a significant correlation with the prevalence of disease (odds ratios (OR) ¼ 0.83, P ¼ 0.04).
Regarding cord blood samples, logistic regression was also carried out and the results are presented in Table 4 . A significant correlation with eczema in children was found for eicosapentaenoic acid (EPA C20:5n3) and docosahexaenoic acid (DHA), with unadjusted OR of 0.44 (P ¼ 0.04) and 0.50 (P ¼ 0.01), respectively. When adjusting for confounders, EPA correlation became non-significant. Therefore, the sum of total n-3 and LC-PUFA n-3 had a significant correlation with the outcome (P ¼ 0.004 for both). Moreover, as in maternal plasma, the total LC-PUFA showed a negative correlation with development of the disease.
DISCUSSION
In this study, the relationships between FA status (cord blood and maternal plasma) and children with atopic eczema were evaluated. The study group was set to avoid the influence of maternal atopy, as described by Hwang et al. 23 Thus, mothers presenting high IgE levels (40.35 kU/l) were excluded from the study. It is obvious that the child's sole source of FA during fetal development is the maternal supply through the umbilical cord. Therefore, analyzing the FA composition of the maternal plasma and cord blood provides a large amount of information about the initial fatty-acid status of the child that can subsequently be related to the development of atopy. Moreover, the composition of maternal plasma is closely affected by dietary FA consumption, 14, 15 so it could provide information on potential dietary recommendations.
When analyzing the levels of FA in both matrices (maternal plasma and cord blood), some dissimilarities were observed ( Table 2) . Thus, increased amounts of n-6 LC-PUFA and n-3 LC-PUFA (especially DHA) in cord blood compared with maternal lipids were found. These differences were previously reported by other authors and could be explained by the special requirements of the fetus. 27 Moreover, there is a wide range of fatty-acid transporters and binding proteins in the placenta that determine the enrichment of these LC-PUFA.
In a German population, Enke et al. 27 found similar values for most individual FA in both matrices to those reported in this study ( Table 2 ). In the case of DHA, levels were much higher in our study; this was probably because of differences between the diets of the mothers in the two populations. However, our values were similar to those reported by other authors for Western individuals who consume a Mediterranean diet.
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The LC-PUFA content in maternal plasma was lower for the group of mothers whose children developed atopic eczema than for mothers of non-atopic children, and when logistic regression was carried out, this LC-PUFA content appeared to have a significant protective role in the development of the disease (Table 3 ). Our finding is in contrast to the study by Newson et al., 29 which revealed no relationship between FA levels in maternal plasma and the development of eczema, although in that case the total amount of LC-PUFA was not evaluated. In a recent study, Noteboom et al. 30 suggested a negative association between the maternal ratio n-6:n-3 and the prevalence of eczema, but we did not observe any significant correlation. In any case, it seems clear that analyzing the cord blood composition should provide further information about the real FA status of the child. 31 Many authors agree with the hypothesis that the consumption of n-3 FA results in a lower risk of developing atopic diseases. 7, 9, 32 Consequently, feeding via the umbilical cord during fetal development, and via breastfeeding during the early stages of life, is particularly interesting. Thus, the relationship between the development of infant atopy and the composition of breast milk [17] [18] [19] [20] and cord blood 16, 21, 22 has been evaluated in numerous research works, but outcomes obtained remain inconclusive. 10 On one hand, most authors found an inverse correlation between the amount of n-3 FA in breast milk or cord blood and the development of atopic diseases. 16, 19, 22, 23, 33 On the other hand, few studies have shown no evidences of a relationship 6, 29 or have even exposed the opposite trend, that is, higher amounts of n-3 FA in samples from atopic individuals than from non-atopics. 17, 18 These latter contradictory results might be explained by the use of a very small number of individuals, especially, in the atopic group, or by the influence of parental atopy, which, in some cases, was not taken into consideration and might be a confounding factor. In this sense, it would be very useful to evaluate the results obtained in different studies, comparing the data and thus, establishing larger and more heterogeneous populations. 34 In our study, cord blood samples from healthy children presented higher amounts of n-3 FA, in particular, EPA and DHA, than samples from atopics. Furthermore, these increased levels of EPA and DHA may also explain the differences found in the ratios n-6:n-3 of total FA and LC-PUFA, which were consequently lower in healthy children compared with atopics. Thus, the study of correlations between cord blood FA and eczema showed that DHA, and also n-3 FA (both n-3 LC-PUFA and total n-3), was negatively correlated with the outcome (Table 4) . In other words, higher levels of n-3 FA, in particular DHA, had a protective role in the development of eczema. The same trend was observed for EPA, but when adjusting for confounders, this correlation became non-significant.
Mechanisms by which elevated concentrations of EPA and DHA disadvantage atopic processes have been hypothesized. 10 N-3 series FA establish a competitive process, with the n-6 series FA, for the substrate in the formation of eicosanoids. Thus, n-3 series FA give rise to eicosanoids with a slightly different structure to those formed from n-6 series FA that are believed to be less potent in inflammatory processes. Moreover, a novel group of mediators derived from n-3 FA, namely E-and D-series resolvins, have recently been identified. These mediators appear to exert anti-inflammatory and inflammation-resolving actions. 
; LC (only FAs with 420 carbons). *P-valueo0.05.
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As described previously, maternal plasma FA barely had influenced atopic eczema. However, strong correlations were observed when their relationship with cord blood FA was studied (data not shown). The FA of each different series was correlated with its analogous FA. Therefore, studying of these correlations lead to the assumption that maternal plasma composition also contributes, to a lesser extent, to the final prevalence of atopic eczema, as it affects cord blood composition.
In summary, this study shows that the fatty-acid composition of maternal plasma and, in particular, its transference via cord blood to the fetus has a considerable impact on childhood health. Thus, lower amounts of n-3 FA, especially DHA in cord blood were detected in children who subsequently developed atopic eczema than in non-atopic children. A lower LC-PUFA content in maternal plasma was also found for this atopic group. As infants with a low risk of developing atopic diseases were studied (that is, those with no parental history of atopy) it can be assumed that maternal diet and fatty-acid transference had a critical role in the development of the disease. Larger studies that include genetic considerations are needed to confirm these findings in order to rule out the influence of other factors involved in immune response. by logistic regression unadjusted and adjusted by sex, maternal social class, maternal education, breastfeeding, maternal smoking during pregnancy and parity. RSFA: C14:0 þ C15:0 þ C16:0 þ C17:0 þ C18:0; RMUFA:C16:1n7 þ C18:1n9n7 þ C20:1n9 þ C24:1; RPUFA:LA þ C18:3n6 þ ALA þ C20:2n6 þ C20:3n9 þ C20:3n6 þ AA þ EPA þ C22:2n6 þ C22:4n6 þ C22:5n6 þ C22:5n3 þ DHA; Rn-3:ALA þ EPA þ C22:5n3 þ DHA. Rn-6:LA þ C18:3n6 þ C20:2n6 þ C20:3n6 þ AA þ C22:2n6 þ C22:4n6 þ C22:5n6; LC (only FAs with 420 carbons). *P-valueo0.05.
